Home >> Clinical Trial Guidance >> Ongoing Clinical Trials
Home >> Clinical Trial Guidance >> Ongoing Clinical Trials
We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.
We inform you of the clinical trials that are being conducted by K-MASTER Precision Medicine Project Group.
* Protocol No. | KM-05 | |||
---|---|---|---|---|
* Research Title | The Effect of EGFR TKI Treatment Based on Liquid Biopsy Panel Screening in Patients with Non-Small Cell Lung Cancer | |||
* Overall Research Director | Kang Jin-Hyoung | Affiliate | Seoul ST. Mary’s Hospital | |
Carcinoma | Non-small cell lung cancer | |||
Target Gene | EGFR/ALK | Clinical Trial Drug | Gefitinib | |
Research period | 2018.06.28 ~ 2021.12.31 | Progress Status | registering | |
Number of recipients | 2 / 105 | Registration rate | 1.9% |
Institutional research participation
No. | Research manager | Research institution |
---|
:: There is no registered research participant information. ::
If you want to participate in the clinical examination, please contact the email address below.
Email kmaster@korea.ac.kr | CONTACT Secretariat 02.2286.1564 | Clinical Trial Coordinating Center 02.2286.1562